Gallery
- PM Modi visit USAOnly the mirror in my washroom and phone gallery see the crazy me : Sara KhanKarnataka rain fury: Photos of flooded streets, uprooted treesCannes 2022: Deepika Padukone stuns at the French Riviera in Sabyasachi outfitRanbir Kapoor And Alia Bhatt's Wedding Pics - Sealed With A KissOscars 2022: Every Academy Award WinnerShane Warne (1969-2022): Australian cricket legend's life in picturesPhotos: What Russia's invasion of Ukraine looks like on the groundLata Mangeshkar (1929-2022): A pictorial tribute to the 'Nightingale of India'PM Modi unveils 216-feet tall Statue of Equality in Hyderabad (PHOTOS)
India Open Competition in Shotgun, organised by the National Rifle Association of India (N
- Hockey India names Amir Ali-led 20-man team for Junior Asia Cup
- Harmanpreet Singh named FIH Player of the Year, PR Sreejesh gets best goalkeeper award
- World Boxing medallist Gaurav Bidhuri to flag off 'Delhi Against Drugs' movement on Nov 17
- U23 World Wrestling Championship: Chirag Chikkara wins gold as India end campaign with nine medals
- FIFA president Infantino confirms at least 9 African teams for the 2026 World Cup
Sputnik V vaccine effective against new variants of coronavirus: Study Last Updated : 13 Jul 2021 01:17:37 PM IST Russia's Sputnik vaccine is effective against all the new variants of the COVID-19, the Gamaleya institute has said. It is developing the vaccine against Covid-19, along with Russia’s sovereign wealth fund, Russian Direct Investment Fund (RDIF).
The Gamaleya institue said that during a study conducted by it, vaccination with Sputnik V has produced protective neutralising titers against new variants, including Alpha (B.1.1.7) - first identified in UK - Beta (B.1.351) - first identified in South Africa - Gamma (P.1) - first identified in Brazil - and Delta (B.1.617.2 and B.1.617.3), first identified in India.The coronavirus vaccine is also able top provide protection against Moscow endemic variants B.1.1.141 and B.1.1.317.The vaccine is a two-dose shot (but two unidentical doses unlike other two-dose vaccines) that is 91.6% effective in preventing serious illness as was found in phase 3 clinical trials.ute further said.For Latest Updates Please-
Join us on
Follow us on
172.31.16.186